A Meddevicetracker report predicts the worldwide market for blood glucose monitoring devices will reach $7.5 billion by 2022 with a 2.4% compound annual growth rate. Last year, the market was led by Roche with a 29% market share, followed by Abbott Laboratories, LifeScan, Ascensia Diabetes Care, Dexcom and Medtronic.
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information
that is changing your industry today, hand-curated by our professional editors from
thousands of sources and delivered straight to your inbox.